.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Express Scripts
Dow
Merck
Chubb
McKinsey
Fuji
Mallinckrodt
Boehringer Ingelheim
Cipla

Generated: December 18, 2017

DrugPatentWatch Database Preview

Remifentanil hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for remifentanil hydrochloride and what is the scope of remifentanil hydrochloride freedom to operate?

Remifentanil hydrochloride
is the generic ingredient in one branded drug marketed by Mylan Institutional and is included in one NDA. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for remifentanil hydrochloride. One supplier is listed for this compound.

Pharmacology for remifentanil hydrochloride

Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan InstitutionalULTIVAremifentanil hydrochlorideINJECTABLE;INJECTION020630-003Jul 12, 1996RXYesYes► Subscribe► SubscribeY► Subscribe
Mylan InstitutionalULTIVAremifentanil hydrochlorideINJECTABLE;INJECTION020630-002Jul 12, 1996RXYesNo► Subscribe► SubscribeY► Subscribe
Mylan InstitutionalULTIVAremifentanil hydrochlorideINJECTABLE;INJECTION020630-001Jul 12, 1996RXYesNo► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: remifentanil hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan InstitutionalULTIVAremifentanil hydrochlorideINJECTABLE;INJECTION020630-003Jul 12, 1996► Subscribe► Subscribe
Mylan InstitutionalULTIVAremifentanil hydrochlorideINJECTABLE;INJECTION020630-001Jul 12, 1996► Subscribe► Subscribe
Mylan InstitutionalULTIVAremifentanil hydrochlorideINJECTABLE;INJECTION020630-003Jul 12, 1996► Subscribe► Subscribe
Mylan InstitutionalULTIVAremifentanil hydrochlorideINJECTABLE;INJECTION020630-002Jul 12, 1996► Subscribe► Subscribe
Mylan InstitutionalULTIVAremifentanil hydrochlorideINJECTABLE;INJECTION020630-002Jul 12, 1996► Subscribe► Subscribe
Mylan InstitutionalULTIVAremifentanil hydrochlorideINJECTABLE;INJECTION020630-001Jul 12, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Baxter
Cerilliant
Accenture
Colorcon
US Army
Cipla
Mallinckrodt
Moodys
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot